These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 12106580)

  • 1. [Updating in prevention and treatment of prostate cancer].
    Marzo Castillejo M; Peña López F; Alonso Coello P; Mascort Roca JJ
    Aten Primaria; 2002 Jun; 30(1):57-63. PubMed ID: 12106580
    [No Abstract]   [Full Text] [Related]  

  • 2. [Adjuvant treatment of prostatic carcinoma after primary therapy. The "Early Prostate Cancer" Program].
    Mansueto G; Longo F
    Recenti Prog Med; 2002 Mar; 93(3):175-8. PubMed ID: 11942169
    [No Abstract]   [Full Text] [Related]  

  • 3. Prostate cancer: non-metastatic.
    Wilt T
    Clin Evid; 2002 Jun; (7):812-23. PubMed ID: 12230707
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of early stage prostate cancer: conservative management--delayed therapy.
    Chodak GW
    Important Adv Oncol; 1994; ():241-4. PubMed ID: 8206492
    [No Abstract]   [Full Text] [Related]  

  • 5. Does androgen deprivation improve treatment outcomes in patients with low-risk and intermediate-risk prostate cancer?
    Miyamoto H; Messing EM; Chang C
    Nat Clin Pract Oncol; 2005 May; 2(5):236-7. PubMed ID: 16264955
    [No Abstract]   [Full Text] [Related]  

  • 6. A systematic review of randomized trials in localized prostate cancer.
    Alibhai SM; Klotz LH
    Can J Urol; 2004 Feb; 11(1):2110-7. PubMed ID: 15003149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent trends in the initial therapy for newly diagnosed prostate cancer in Japan.
    Onozawa M; Hinotsu S; Tsukamoto T; Oya M; Ogawa O; Kitamura T; Suzuki K; Naito S; Namiki M; Nishimura K; Hirao Y; Akaza H
    Jpn J Clin Oncol; 2014 Oct; 44(10):969-81. PubMed ID: 25098707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate cancer (non-metastatic).
    Wilt T
    Clin Evid; 2003 Jun; (9):973-85. PubMed ID: 12967402
    [No Abstract]   [Full Text] [Related]  

  • 9. Patient-Reported Outcomes Through 5 Years for Active Surveillance, Surgery, Brachytherapy, or External Beam Radiation With or Without Androgen Deprivation Therapy for Localized Prostate Cancer.
    Hoffman KE; Penson DF; Zhao Z; Huang LC; Conwill R; Laviana AA; Joyce DD; Luckenbaugh AN; Goodman M; Hamilton AS; Wu XC; Paddock LE; Stroup A; Cooperberg MR; Hashibe M; O'Neil BB; Kaplan SH; Greenfield S; Koyama T; Barocas DA
    JAMA; 2020 Jan; 323(2):149-163. PubMed ID: 31935027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Established and new urological therapeutic options in the management of prostate carcinoma].
    Michel MS; Trojan L; Knoll T; Bross S; Alken P
    Radiologe; 2003 Jun; 43(6):441-7. PubMed ID: 12827258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neoadjuvant hormonal deprivation in locally advanced prostate cancer: does it make sense?
    Schulman CC; Wildschutz TP
    Acta Urol Belg; 1996 May; 64(2):57-61. PubMed ID: 8701814
    [No Abstract]   [Full Text] [Related]  

  • 12. [Adjuvant hormone therapy in prostatic cancer: after treatment with curative intent. The viewpoint of the urologist].
    Martorana G
    Recenti Prog Med; 2002 Mar; 93(3):179-82. PubMed ID: 11942170
    [No Abstract]   [Full Text] [Related]  

  • 13. [Differential therapy of prostate cancer].
    Jäger T; Rübben H; Börgermann C
    Internist (Berl); 2007 Dec; 48(12):1382-7. PubMed ID: 17965846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Critical evaluation of hormonal therapy for carcinoma of the prostate.
    Chodak GW; Keane T; Klotz L;
    Urology; 2002 Aug; 60(2):201-8. PubMed ID: 12137810
    [No Abstract]   [Full Text] [Related]  

  • 15. [Prostate cancer: evolution of approach].
    Vorob'ëv AV
    Vopr Onkol; 2009; 55(2):241-9. PubMed ID: 19514384
    [No Abstract]   [Full Text] [Related]  

  • 16. Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy With Brachytherapy Boost and Disease Progression and Mortality in Patients With Gleason Score 9-10 Prostate Cancer.
    Kishan AU; Cook RR; Ciezki JP; Ross AE; Pomerantz MM; Nguyen PL; Shaikh T; Tran PT; Sandler KA; Stock RG; Merrick GS; Demanes DJ; Spratt DE; Abu-Isa EI; Wedde TB; Lilleby W; Krauss DJ; Shaw GK; Alam R; Reddy CA; Stephenson AJ; Klein EA; Song DY; Tosoian JJ; Hegde JV; Yoo SM; Fiano R; D'Amico AV; Nickols NG; Aronson WJ; Sadeghi A; Greco S; Deville C; McNutt T; DeWeese TL; Reiter RE; Said JW; Steinberg ML; Horwitz EM; Kupelian PA; King CR
    JAMA; 2018 Mar; 319(9):896-905. PubMed ID: 29509865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early versus deferred androgen suppression in the treatment of advanced prostatic cancer.
    Nair B; Wilt T; MacDonald R; Rutks I
    Cochrane Database Syst Rev; 2002; (1):CD003506. PubMed ID: 11869665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical stage T3 prostate cancer: natural history, therapeutic choices and their results].
    Peneau M; Piéchaud T; Cariou G; Ragni E; Fontaine E; Fournier G
    Prog Urol; 1998 Dec; 8(6):977-93. PubMed ID: 9894256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health related quality of life in Japanese men with localized prostate cancer treated with current multiple modalities assessed by a newly developed Japanese version of the Expanded Prostate Cancer Index Composite.
    Kakehi Y; Takegami M; Suzukamo Y; Namiki S; Arai Y; Kamoto T; Ogawa O; Fukuhara S
    J Urol; 2007 May; 177(5):1856-61. PubMed ID: 17437836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prostate cancer: at the beginning of a new millennium].
    Tombal B; Van Cangh PJ
    Acta Urol Belg; 2000; 68(2):29-33. PubMed ID: 11098584
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.